Welcome to the e-CCO Library Archive!

Filter:
P122. Extraintestinal manifestations in a single centre cohort of chronic inflammatory bowel disease patients
P122. The natural history of Crohn's disease: Impact of the introduction of thiopurines on its outcome
P122. Validation of the International Classification of Functioning, Disability and Health score: a measure of disability in inflammatory bowel diseases
Authors:

R. Leong1, T. Huang1, Y. Ko1, V. Kariyawasam1, 1Concord Hospital Inflammatory Bowel Diseases Service, Concord Hospital Gastroenterology and Liver Services, Sydney, Australia

P122

Rectal bleeding accurately reflects mucosal inflammation in patients with Ulcerative Colitis

Authors:

M. Keir*1, C. Cabanski2, R. Zhao2, J.-F. Colombel3, J. Panes4, T. Lu5, W. Faubion6, J. Fletcher7, B. Feagan8, P. Kulkarni2, P. Higgins9, G. de Hertogh10, G. van Assche11, J. Mansfield12, W. Sandborn13, P. Rutgeerts14, S. Vermeire14, S. O'Byrne2

1Genentech Research & Early Development, ITGR Diagnostic Discovery, South San Francisco, United States, 2Genentech, Research and Early Development, South San Francisco, United States, 3Icahn School of Medicine at Mount Sinai, Department of Gastroenterology, New York, United States, 4Hospital Clinic de Barcelona, IDIBAPS and CIBERehd, Gastroenterology Unit, Barcelona, Spain, 5Genentech, Early Clinical Development, South San Francisco, United States, 6Mayo Clinic, Division of Gastroenterology & Hepatology, Rochester, United States, 7Mayo Clinic, Radiology, Rochester, MN, United States, 8Robarts Clinical Trials Inc., Robarts Research Institute, University of Western Ontario, London, Ontario, Canada, 9University of Michigan, Internal Medicine - Gastroenterology, Ann Arbor, MI, United States, 10University Hospitals Leuven, Department of Pathology, Leuven, Belgium, 11University Hospital Leuven, Gastroenterology, Leuven, Belgium, 12Newcastle University, Department of Gastroenterology, Newcastle Upon Tyne, United Kingdom, 13University of California San Diego, Division of Gastroenterology, La Jolla, United States, 14KU Leuven, Division of Gastroenterology, Leuven, Belgium

P123.

The use of faecal calprotectin in IBD and reducing unnecessary colonoscopy

Authors:

M. Johnson1, K. Lithgo1, T. Price2, T. Cacciattolo1, S. Steve1, 1Luton & Dunstable University Hospital foundation trust NHS, Gastroenterology, Luton, United Kingdom, 2The Luton & Dunstable University Hospital Foundation Trust NHS, Gastroenterology, Luton, United Kingdom

P123. Accuracy of endoscopic capsule in Crohn's disease diagnosis in an experienced unit
P123. Impact of magnetic resonance enterography on decision-making in small-bowel Crohn's disease
P123. Use of soluble transferrin receptor/log10 ferritin index as a predictor of response to intravenous iron administration in patients with inflammatory bowel disease and anemia
Authors:

C. Georgousaki1, P. Oustamanolakis1, S. Terzoudis1, E. Kouroumalis1, I. Koutroubakis1, 1University Hospital Heraklion, Gastroenterology, Heraklion, Greece

P123

A single center experience with small bowel capsule endoscopy for patients with established Crohn's Disease: In which patients are lesions found?

Authors:

N. Viazis*, J. Anastasiou, T. Koukouratos, K. Katopodi, L. Varitimiadis, S. Anastasiadis, P. Karatzas, G. Kechagias, D. Karamanolis

Evangelismos Hospital, Gastroenterology Department, Athens, Greece

P124.

The Modified Mayo Endoscopic Score (MMES): a new score for the assessment of extent and severity of endoscopic activity in ulcerative colitis (UC) patients

Authors:

T. Lobaton Ortega1,2, T. Bessissow3, G. De Hertogh4, G. Van Assche2, S. Vermeire2, P. Rutgeerts2, R. Bisschops5, A. Bitton3, W. Afif6, M. Ferrante2, 1Bellvitge University Hospital, Gastroenterology, Barcelona, Spain, 2University Hospital Leuven, Gastroenterology, Leuven, Belgium, 3MUHC Royal Victoria Hospital, Gastroenterology, Montreal, Canada, 4University Hospital Leuven, Pathology, Leuven, Belgium, 5University Hospital Leuven, Endoscopy, Leuven, Belgium, 6MUHC Royal Victoria Hospital, Gastroenterology, Leuven, Canada

P124. Frequency of opportunistic virus infections in patients with inflammatory bowel diseases in Moscow region
P124. Mucosal healing in ulcerative colitis: No relation between histology and clinical findings
P124. Use of interferon-gamma release assay (IGRA) and tuberculin skin test (TST) for tuberculosis screening in patients candidates for anti-TNF terapy in inflammatory bowel disease (IBD)
Authors:

S. Fernandez1, J. Riera1, N. Balza1, M. Garcia2, A. Serrano2, M. Trelles1, H.J. Canaval1, R. Chachi1, C. Dolz1, 1Hospital Son Llàtzer, Gastroenterology, Spain, 2Hospital Son Llàtzer, Internal Medicine, Spain

P124

Iron deficiency in the absence of anemia affects the perception of health-related quality of life in IBD patients in remission

Authors:

C. Herrera*, V. Robles, E. Navarro, N. Borruel, F. Casellas

Unitat Atenció Crohn-Colitis. Hospital Universitari Vall d'Hebron, Digestive System Research Unit, Barcelona, Spain

P125.

The effect of suppressing gastric acid secretion in Crohn's disease

Authors:

Y.M. Han1, S.J. Koh2, J.W. Kim2, J.P. Im1, J.S. Kim1, 1Seoul National University College of Medicine, Department of Internal Medicine and Liver Research Institute, Seoul, Korea, Republic of, 2Seoul National University College of Medicine, Department of Internal Medicine, Seoul National University Boramae Hospital, Seoul, Korea, Republic of

P125. A prospective study of the ileal gut hormone fibroblast growth factor 19 (FGF19) in ileal Crohn's disease
P125. Prevalence of metabolic syndrome in a Turkish population with inflammatory bowel disease
P125. Ultrasensitive C reactive protein is a marker of endoscopic relapse in patients with ulcerative colitis
Authors:

J. Yamamoto-Furusho1, W. Cedillo-Suárez1, C. Campos-González1, R. Barreto-Zuñiga1, 1IBD Clinic, Instituto Nacional de Ciencias Medicas y Nutricion, Gastroenterology, Mexico, Mexico

P125

Developments of novel diagnostic findings on capsule endoscopy in the small bowel of patients with Crohn's disease

Authors:

K. Watanabe*1, A. Noguchi2, T. MIyazaki3, K. Morimoto2, S. Hosomi2, T. Yukawa2, N. Kamata2, H. Yamgami2, S. Nakamura3, T. Arakawa2

1Osaka City General Hospital, Gastroenterology, Osaka, Japan, 2Osaka City University, Gastroenterology, Osaka, Japan, 3Hyogo College of Medicine, Inflammatory Bowel Disease, Nishinomiya, Japan

P126.

The Belgian Registry of Pediatric Crohn's disease (BELCRO): growth status after 3 year follow up

Authors:

E. De Greef1, J.M. Mahachie John2, I. Hoffman3, F. Smets4, S. Van Biervliet5, P. Bontems6, I. Paquot7, P. Alliet8, K. Van Steen2, G. Veereman1, 1UZ Brussel, Pediatric Gastroenterology, Jette, Belgium, 2Montefiori Institute, Systems and Modelling Unit, Liege, Belgium, 3UZ Gasthuisberg, Pediatric Gastroenterology, Leuven, Belgium, 4UCL St Luc, Pediatric Gastroenterology, Brussels, Belgium, 5UZ Gent, Pediatric Gastroenterology, Gent, Belgium, 6HUDERF, Pediatric Gastroenterology, Brussels, Belgium, 7CHC de l'espérance, Pediatric Gastroenterology, Liège, Belgium, 8Jessa Hospital, Pediatric Gastroenterology, Hasselt, Belgium